Triple negative breast cancer in the era of miRNA.
Sabit H, Cevik E, Tombuloglu H, Abdel-Ghany S, Tombuloglu G, Esteller M.
Sabit H, et al. Among authors: tombuloglu h, tombuloglu g.
Crit Rev Oncol Hematol. 2021 Jan;157:103196. doi: 10.1016/j.critrevonc.2020.103196. Epub 2020 Dec 9.
Crit Rev Oncol Hematol. 2021.
PMID: 33307198
Review.